Predictive factors for prostate cancer in biopsy of patients with prostate-specific antigen levels equal to or less than 4 ng/ml
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, H.W. | - |
dc.contributor.author | Ko, Y.H. | - |
dc.contributor.author | Kang, S.H. | - |
dc.contributor.author | Lee, J.G. | - |
dc.date.accessioned | 2021-09-07T20:52:19Z | - |
dc.date.available | 2021-09-07T20:52:19Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 2005-6737 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/114721 | - |
dc.description.abstract | Purpose: This study was conducted to identify the predictive factors for prostate cancer in patients with prostate-specific antigen (PSA) levels equal to or less than 4 ng/ml. Materials and Methods: A retrospective study of medical records was conducted on 292 patients with initial serum PSA ≤4 ng/ml among 2,305 patients who underwent prostate biopsy from January 2003 to December 2008. Prostate biopsy was performed on patients with PSA ≤4 ng/ml in the case of abnormal findings in the digital rectal examination (DRE) or transrectal ultrasonography (TRUS) or in those with a PSA level higher than the age-adjusted PSA levels. The patients were divided into the group diagnosed with prostate cancer and the non-prostate-cancer group. Subsequently, the variables of the two groups were compared. Results: The patients' mean age was significantly higher in the prostate cancer group (n=28) than in the non-prostate-cancer group (n=264; p=0.033). In addition, for the patients with a PSA range of 2.0-2.9 ng/ml, their age (p=0.049) and PSA density (PSAD; p=0.042) were significantly higher and the prostate volume (p=0.028) was significantly smaller in the prostate cancer group than in the non-prostate-cancer group. Conclusions: Of the patients with PSA ≤4 ng/ml, the age of the patients who showed abnormal findings in the DRE or TRUS or who had a PSA level higher than the age-adjusted PSA level was a significant predictive factor for prostate cancer. In particular, for the PSA range of 2.0-2.9 ng/ml, a thorough screening test for prostate cancer was required if the patients had conditions such as higher age, smaller prostate, and higher PSAD. © The Korean Urological Association, 2011. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | prostate specific antigen | - |
dc.subject | adult | - |
dc.subject | aged | - |
dc.subject | aging | - |
dc.subject | article | - |
dc.subject | cancer screening | - |
dc.subject | controlled study | - |
dc.subject | digital rectal examination | - |
dc.subject | human | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | prediction | - |
dc.subject | predictive value | - |
dc.subject | prostate biopsy | - |
dc.subject | prostate cancer | - |
dc.subject | retrospective study | - |
dc.subject | transrectal ultrasonography | - |
dc.title | Predictive factors for prostate cancer in biopsy of patients with prostate-specific antigen levels equal to or less than 4 ng/ml | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ko, Y.H. | - |
dc.contributor.affiliatedAuthor | Kang, S.H. | - |
dc.contributor.affiliatedAuthor | Lee, J.G. | - |
dc.identifier.doi | 10.4111/kju.2011.52.3.166 | - |
dc.identifier.scopusid | 2-s2.0-79953199082 | - |
dc.identifier.bibliographicCitation | Korean Journal of Urology, v.52, no.3, pp.166 - 171 | - |
dc.relation.isPartOf | Korean Journal of Urology | - |
dc.citation.title | Korean Journal of Urology | - |
dc.citation.volume | 52 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 166 | - |
dc.citation.endPage | 171 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | prostate specific antigen | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | aging | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cancer screening | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | digital rectal examination | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | prediction | - |
dc.subject.keywordPlus | predictive value | - |
dc.subject.keywordPlus | prostate biopsy | - |
dc.subject.keywordPlus | prostate cancer | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | transrectal ultrasonography | - |
dc.subject.keywordAuthor | Prostate-specific antigen | - |
dc.subject.keywordAuthor | Prostatic neoplasms | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.